RUIU, ROBERTO
RUIU, ROBERTO
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
2022-01-01 Ruiu R.; Di Lorenzo A.; Cavallo F.; Conti L.
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells
2018-01-01 Donofrio, Gaetano; Tebaldi, Giulia; Lanzardo, Stefania; Ruiu, Roberto; Bolli, Elisabetta; Ballatore, Andrea; Rolih, Valeria; Macchi, Francesca; Conti, Laura; Cavallo, Federica*
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
2019-01-01 Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L.
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
2018-01-01 Witt, Kristina; Ligtenberg, Maarten A.; Conti, Laura; Lanzardo, Stefania; Ruiu, Roberto; Wallmann, Tatjana; Tufvesson-Stiller, Helena; Chambers, Benedict J.; Rolny, Charlotte; Lladser, Alvaro; Lundqvist, Andreas; Cavallo, Federica; Kiessling, Rolf
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models
2023-01-01 Ruiu R.; Cossu C.; Iacoviello A.; Conti L.; Bolli E.; Ponzone L.; Magri J.; Rumandla A.; Calautti E.; Cavallo F.
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
2019-01-01 Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura
Identification and Evaluation of Molecular Targets Associated to the Cancer Stem Cell Phenotype in Mammary Tumor
2018-03-04
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker.
2021-01-01 Peppino G., Barutello G., Ruiu R., Arigoni M., Riccardo F., Conti L., Calogero R.A., Quaglino E.
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer
2021-01-01 Ruiu R.; Barutello G.; Arigoni M.; Riccardo F.; Conti L.; Peppino G.; Annaratone L.; Marchio C.; Mengozzi G.; Calogero R.A.; Cavallo F.; Quaglino E.
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer
2016-01-01 Lanzardo, Stefania; Conti, Laura; Rooke, Ronald; Ruiu, Roberto; Accart, Nathalie; Bolli, Elisabetta; Arigoni, Maddalena; Macagno, Marco; Barrera, Giuseppina; Pizzimenti, Stefania; Aurisicchio, Luigi; Calogero, Raffaele Adolfo; Cavallo, Federica
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
2020-01-01 Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F.
Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model
2021-01-01 Ruggiero, Maria Rosaria; Baroni, Simona; Bitonto, Valeria; Ruiu, Roberto; Rapisarda, Smeralda; Aime, Silvio; Geninatti Crich, Simonetta
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents
2016-01-01 Conti, Laura; Lanzardo, Stefania; Ruiu, Roberto; Cadenazzi, Marta; Cavallo, Federica; Aime, Silvio; Geninatti Crich, Simonetta
L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer
2020-01-01 Bitonto V.; Alberti D.; Ruiu R.; Aime S.; Geninatti Crich S.; Cutrin J.C.
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
2014-01-01 Laura Conti;Roberto Ruiu;Giuseppina Barutello;Marco Macagno;Silvio Bandini;Federica Cavallo;Stefania Lanzardo
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells
2015-01-01 Geninatti Crich, S; Cadenazzi, M.; Lanzardo, S.; Conti, L.; Ruiu, R.; Alberti, D.; Cavallo, F.; Cutrin, J.C.; Aime, S.
Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy
2021-01-01 Peppino, Giulia; Ruiu, Roberto; Arigoni, Maddalena; Riccardo, Federica; Iacoviello, Antonella; Barutello, Giuseppina; Quaglino, Elena
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis
2016-01-01 Bandini, Silvio; Macagno, Marco; Hysi, Albana; Lanzardo, Stefania; Conti, Laura; Bello, Amanda; Riccardo, Federica; Ruiu, Roberto; Merighi, Irene Fiore; Forni, Guido; Iezzi, Manuela; Quaglino, Elena; Cavallo, Federica
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy
2022-01-01 Di Lorenzo, Antonino; Bolli, Elisabetta; Ruiu, Roberto; Ferrauto, Giuseppe; Di Gregorio, Enza; Avalle, Lidia; Savino, Aurora; Poggio, Pietro; Merighi, Irene Fiore; Riccardo, Federica; Brancaccio, Mara; Quaglino, Elena; Cavallo, Federica; Conti, Laura
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
2021-01-01 Magri J.; Gasparetto A.; Conti L.; Calautti E.; Cossu C.; Ruiu R.; Barutello G.; Cavallo F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? | 2022 | Ruiu R.; Di Lorenzo A.; Cavallo F.; Conti L. | |
| Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells | 2018 | Donofrio, Gaetano; Tebaldi, Giulia; Lanzardo, Stefania; Ruiu, Roberto; Bolli, Elisabetta; Ballatore, Andrea; Rolih, Valeria; Macchi, Francesca; Conti, Laura; Cavallo, Federica* | |
| Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source | 2019 | Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L. | |
| Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma | 2018 | Witt, Kristina; Ligtenberg, Maarten A.; Conti, Laura; Lanzardo, Stefania; Ruiu, Roberto; Wallmann, Tatjana; Tufvesson-Stiller, Helena; Chambers, Benedict J.; Rolny, Charlotte; Lladser, Alvaro; Lundqvist, Andreas; Cavallo, Federica; Kiessling, Rolf | |
| Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models | 2023 | Ruiu R.; Cossu C.; Iacoviello A.; Conti L.; Bolli E.; Ponzone L.; Magri J.; Rumandla A.; Calautti E.; Cavallo F. | |
| Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter | 2019 | Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura | |
| Identification and Evaluation of Molecular Targets Associated to the Cancer Stem Cell Phenotype in Mammary Tumor | 2018 | - | |
| Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. | 2021 | Peppino G., Barutello G., Ruiu R., Arigoni M., Riccardo F., Conti L., Calogero R.A., Quaglino E. | |
| Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer | 2021 | Ruiu R.; Barutello G.; Arigoni M.; Riccardo F.; Conti L.; Peppino G.; Annaratone L.; Marchio C.; Mengozzi G.; Calogero R.A.; Cavallo F.; Quaglino E. | |
| Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer | 2016 | Lanzardo, Stefania; Conti, Laura; Rooke, Ronald; Ruiu, Roberto; Accart, Nathalie; Bolli, Elisabetta; Arigoni, Maddalena; Macagno, Marco; Barrera, Giuseppina; Pizzimenti, Stefania; Aurisicchio, Luigi; Calogero, Raffaele Adolfo; Cavallo, Federica | |
| Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer | 2020 | Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F. | |
| Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model | 2021 | Ruggiero, Maria Rosaria; Baroni, Simona; Bitonto, Valeria; Ruiu, Roberto; Rapisarda, Smeralda; Aime, Silvio; Geninatti Crich, Simonetta | |
| L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents | 2016 | Conti, Laura; Lanzardo, Stefania; Ruiu, Roberto; Cadenazzi, Marta; Cavallo, Federica; Aime, Silvio; Geninatti Crich, Simonetta | |
| L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer | 2020 | Bitonto V.; Alberti D.; Ruiu R.; Aime S.; Geninatti Crich S.; Cutrin J.C. | |
| Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice | 2014 | Laura Conti;Roberto Ruiu;Giuseppina Barutello;Marco Macagno;Silvio Bandini;Federica Cavallo;Stefania Lanzardo | |
| Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells | 2015 | Geninatti Crich, S; Cadenazzi, M.; Lanzardo, S.; Conti, L.; Ruiu, R.; Alberti, D.; Cavallo, F.; Cutrin, J.C.; Aime, S. | |
| Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy | 2021 | Peppino, Giulia; Ruiu, Roberto; Arigoni, Maddalena; Riccardo, Federica; Iacoviello, Antonella; Barutello, Giuseppina; Quaglino, Elena | |
| The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis | 2016 | Bandini, Silvio; Macagno, Marco; Hysi, Albana; Lanzardo, Stefania; Conti, Laura; Bello, Amanda; Riccardo, Federica; Ruiu, Roberto; Merighi, Irene Fiore; Forni, Guido; Iezzi, Manuela; Quaglino, Elena; Cavallo, Federica | |
| Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy | 2022 | Di Lorenzo, Antonino; Bolli, Elisabetta; Ruiu, Roberto; Ferrauto, Giuseppe; Di Gregorio, Enza; Avalle, Lidia; Savino, Aurora; Poggio, Pietro; Merighi, Irene Fiore; Riccardo, Federica; Brancaccio, Mara; Quaglino, Elena; Cavallo, Federica; Conti, Laura | |
| Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies | 2021 | Magri J.; Gasparetto A.; Conti L.; Calautti E.; Cossu C.; Ruiu R.; Barutello G.; Cavallo F. |